Journalartikel
Autorenliste: Hunzelmann, N.; Riemekasten, G.; Becker, M. O.; Moinzadeh, P.; Kreuter, A.; Melchers, I.; Mueller-Ladner, U.; Meier, F.; Worm, M.; Lee, H.; Herrgott, I.; Pfeiffer, C.; Fierlbeck, G.; Henes, J.; Juche, A.; Zeidler, G.; Mensing, H.; Guenther, C.; Sardy, M.; Burkhardt, H.; Koehm, M.; Kuhr, K.; Krieg, T.; Sunderkoetter, C.
Jahr der Veröffentlichung: 2016
Seiten: 1384-1387
Zeitschrift: British Journal of Dermatology
Bandnummer: 174
Heftnummer: 6
ISSN: 0007-0963
eISSN: 1365-2133
Open Access Status: Hybrid
DOI Link: https://doi.org/10.1111/bjd.14367
Verlag: Oxford University Press
Zitierstile
Harvard-Zitierstil: Hunzelmann, N., Riemekasten, G., Becker, M., Moinzadeh, P., Kreuter, A., Melchers, I., et al. (2016) The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodies, British Journal of Dermatology, 174(6), pp. 1384-1387. https://doi.org/10.1111/bjd.14367
APA-Zitierstil: Hunzelmann, N., Riemekasten, G., Becker, M., Moinzadeh, P., Kreuter, A., Melchers, I., Mueller-Ladner, U., Meier, F., Worm, M., Lee, H., Herrgott, I., Pfeiffer, C., Fierlbeck, G., Henes, J., Juche, A., Zeidler, G., Mensing, H., Guenther, C., Sardy, M., ...Sunderkoetter, C. (2016). The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodies. British Journal of Dermatology. 174(6), 1384-1387. https://doi.org/10.1111/bjd.14367
Schlagwörter
CLINICAL-FEATURES; COHORT; GERMAN NETWORK; MULTICENTER; REGISTRY; SCLERODERMA
